780 related articles for article (PubMed ID: 30851296)
1. Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies.
Pham TH; Gardier AM
Pharmacol Ther; 2019 Jul; 199():58-90. PubMed ID: 30851296
[TBL] [Abstract][Full Text] [Related]
2. Cortical and raphe GABA
Pham TH; Defaix C; Nguyen TML; Mendez-David I; Tritschler L; David DJ; Gardier AM
Pharmacol Biochem Behav; 2020 May; 192():172913. PubMed ID: 32201299
[TBL] [Abstract][Full Text] [Related]
3. [Ketamine: a neuropsychotropic drug with an innovative mechanism of action].
Guilloux JP; Nguyen TML; Gardier AM
Biol Aujourdhui; 2023; 217(3-4):133-144. PubMed ID: 38018940
[TBL] [Abstract][Full Text] [Related]
4. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2
Fukumoto K; Fogaça MV; Liu RJ; Duman C; Kato T; Li XY; Duman RS
Proc Natl Acad Sci U S A; 2019 Jan; 116(1):297-302. PubMed ID: 30559184
[TBL] [Abstract][Full Text] [Related]
5. Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice.
Pham TH; Mendez-David I; Defaix C; Guiard BP; Tritschler L; David DJ; Gardier AM
Neuropharmacology; 2017 Jan; 112(Pt A):198-209. PubMed ID: 27211253
[TBL] [Abstract][Full Text] [Related]
6. A hypothesis of monoamine (5-HT) - Glutamate/GABA long neural circuit: Aiming for fast-onset antidepressant discovery.
Li YF
Pharmacol Ther; 2020 Apr; 208():107494. PubMed ID: 31991195
[TBL] [Abstract][Full Text] [Related]
7. cAMP-dependent protein kinase signaling is required for (
Riggs LM; Pereira EFR; Thompson SM; Gould TD
J Neurophysiol; 2024 Jan; 131(1):64-74. PubMed ID: 38050689
[TBL] [Abstract][Full Text] [Related]
8. Repeated ketamine treatment induces sex-specific behavioral and neurochemical effects in mice.
Thelen C; Sens J; Mauch J; Pandit R; Pitychoutis PM
Behav Brain Res; 2016 Oct; 312():305-12. PubMed ID: 27343934
[TBL] [Abstract][Full Text] [Related]
9. The Antidepressant Effects of an mGlu2/3 Receptor Antagonist and Ketamine Require AMPA Receptor Stimulation in the mPFC and Subsequent Activation of the 5-HT Neurons in the DRN.
Fukumoto K; Iijima M; Chaki S
Neuropsychopharmacology; 2016 Mar; 41(4):1046-56. PubMed ID: 26245499
[TBL] [Abstract][Full Text] [Related]
10. Serotonergic mechanisms involved in antidepressant-like responses evoked by GLT-1 blockade in rat infralimbic cortex.
Gasull-Camós J; Martínez-Torres S; Tarrés-Gatius M; Ozaita A; Artigas F; Castañé A
Neuropharmacology; 2018 Sep; 139():41-51. PubMed ID: 29940206
[TBL] [Abstract][Full Text] [Related]
11. Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.
Kokane SS; Armant RJ; Bolaños-Guzmán CA; Perrotti LI
Behav Brain Res; 2020 Apr; 384():112548. PubMed ID: 32061748
[TBL] [Abstract][Full Text] [Related]
12. Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit.
Yao N; Skiteva O; Zhang X; Svenningsson P; Chergui K
Mol Psychiatry; 2018 Oct; 23(10):2066-2077. PubMed ID: 29158578
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant actions of ketamine engage cell-specific translation via eIF4E.
Aguilar-Valles A; De Gregorio D; Matta-Camacho E; Eslamizade MJ; Khlaifia A; Skaleka A; Lopez-Canul M; Torres-Berrio A; Bermudez S; Rurak GM; Simard S; Salmaso N; Gobbi G; Lacaille JC; Sonenberg N
Nature; 2021 Feb; 590(7845):315-319. PubMed ID: 33328636
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant-relevant concentrations of the ketamine metabolite (2
Lumsden EW; Troppoli TA; Myers SJ; Zanos P; Aracava Y; Kehr J; Lovett J; Kim S; Wang FH; Schmidt S; Jenne CE; Yuan P; Morris PJ; Thomas CJ; Zarate CA; Moaddel R; Traynelis SF; Pereira EFR; Thompson SM; Albuquerque EX; Gould TD
Proc Natl Acad Sci U S A; 2019 Mar; 116(11):5160-5169. PubMed ID: 30796190
[TBL] [Abstract][Full Text] [Related]
15. Intranasal (R, S)-ketamine delivery induces sustained antidepressant effects associated with changes in cortical balance of excitatory/inhibitory synaptic activity.
Nguyen TML; Defaix C; Mendez-David I; Tritschler L; Etting I; Alvarez JC; Choucha W; Colle R; Corruble E; David DJ; Gardier AM
Neuropharmacology; 2023 Mar; 225():109357. PubMed ID: 36462636
[TBL] [Abstract][Full Text] [Related]
16. Ketamine rapidly reverses stress-induced impairments in GABAergic transmission in the prefrontal cortex in male rodents.
Ghosal S; Duman CH; Liu RJ; Wu M; Terwilliger R; Girgenti MJ; Wohleb E; Fogaca MV; Teichman EM; Hare B; Duman RS
Neurobiol Dis; 2020 Feb; 134():104669. PubMed ID: 31707118
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the rat.
Björkholm C; Frånberg O; Malmerfelt A; Marcus MM; Konradsson-Geuken Å; Schilström B; Jardemark K; Svensson TH
Int J Neuropsychopharmacol; 2014 Oct; 18(3):. PubMed ID: 25522408
[TBL] [Abstract][Full Text] [Related]
18. Ketamine-like effects of a combination of olanzapine and fluoxetine on AMPA and NMDA receptor-mediated transmission in the medial prefrontal cortex of the rat.
Björkholm C; Jardemark K; Schilström B; Svensson TH
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1842-7. PubMed ID: 26233606
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Relationship of Ketamine Dose With Magnetic Resonance Spectroscopy of Glx and GABA Responses in Adults With Major Depression: A Randomized Clinical Trial.
Milak MS; Rashid R; Dong Z; Kegeles LS; Grunebaum MF; Ogden RT; Lin X; Mulhern ST; Suckow RF; Cooper TB; Keilp JG; Mao X; Shungu DC; Mann JJ
JAMA Netw Open; 2020 Aug; 3(8):e2013211. PubMed ID: 32785636
[TBL] [Abstract][Full Text] [Related]
20. Synaptic mechanisms underlying rapid antidepressant action of ketamine.
Kavalali ET; Monteggia LM
Am J Psychiatry; 2012 Nov; 169(11):1150-6. PubMed ID: 23534055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
